Pfizer Manufacturing Belgium NV (manufacturing, primary packaging (cartridge), testing of medicinal solution (endotoxins, sterility, m-cresol) (cartridge); assembly, labeling, testing and secondary packaging of pre-filled pen; batch release)

Ukraine

All drugs from this manufacturer

  • ENJENLA

    The drug is intended for the treatment of children and adolescents aged 3 years and older who exhibit growth impairment due to growth hormone deficiency.

    Dosage form: solution for injection

    Active substance Dosage
    somatropin 20 mg/ml

    ATC: H01AC08

  • The drug is intended for the treatment of children and adolescents aged 3 years and older who exhibit growth impairment due to insufficient growth hormone secretion.

    Dosage form: solution for injection

    Active substance Dosage
    somatropin 50 mg/ml

    ATC: H01AC08